Statement of Retraction: The role of second generation sequencing technology and nanomedicine in the monitoring and treatment of lower extremity deep vein thrombosis susceptibility genes.

IF 4.2 4区生物学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Bioengineered Pub Date : 2024-12-01 Epub Date: 2024-01-29 DOI:10.1080/21655979.2024.2302653

引用次数: 0

查看原文本刊更多论文

撤回声明：第二代测序技术和纳米医学在下肢深静脉血栓易感基因监测和治疗中的作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Bioengineered BIOTECHNOLOGY & APPLIED MICROBIOLOGY-

CiteScore

8.20

自引率

28.60%

发文量

1114

审稿时长

17 weeks

期刊介绍： Bioengineered provides a platform for publishing high quality research on any aspect of genetic engineering which involves the generation of recombinant strains (both prokaryote and eukaryote) for beneficial applications in food, medicine, industry, environment and bio-defense.